scholarly article | Q13442814 |
P356 | DOI | 10.1124/MOL.116.105015 |
P698 | PubMed publication ID | 27683013 |
P50 | author | Arthur Christopoulos | Q18977850 |
Patrick M. Sexton | Q39936838 | ||
Karen J. Gregory | Q42574240 | ||
Peter J. Scammells | Q46042717 | ||
Trayder Thomas | Q64399275 | ||
Lauren T May | Q96202346 | ||
Elizabeth A Vecchio | Q114366402 | ||
P2093 | author name string | Paul J White | |
Luigi Aurelio | |||
Toan D Nguyen | |||
Anh T N Nguyen | |||
P2860 | cites work | Structure of an agonist-bound human A2A adenosine receptor | Q24296388 |
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation | Q24303747 | ||
Activation and allosteric modulation of a muscarinic acetylcholine receptor | Q24308061 | ||
CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields | Q24632987 | ||
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist | Q24654563 | ||
Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine | Q27672832 | ||
All-atom empirical potential for molecular modeling and dynamics studies of proteins | Q27860468 | ||
VMD: visual molecular dynamics | Q27860554 | ||
Scalable molecular dynamics with NAMD | Q27860718 | ||
How many drug targets are there? | Q28276660 | ||
Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations | Q29547631 | ||
Pocketome via comprehensive identification and classification of ligand binding envelopes. | Q30350345 | ||
The second extracellular loop of the adenosine A1 receptor mediates activity of allosteric enhancers | Q30408394 | ||
Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties | Q30498538 | ||
Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias | Q33748133 | ||
Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: identification of ligand-specific and global activation mechanisms. | Q33911197 | ||
The effect of allosteric modulators on the kinetics of agonist-G protein-coupled receptor interactions in single living cells | Q34127977 | ||
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery | Q34139176 | ||
The flexible pocketome engine for structural chemogenomics | Q34286648 | ||
Extension of the CHARMM General Force Field to sulfonyl-containing compounds and its utility in biomolecular simulations. | Q34347574 | ||
G protein-coupled receptor allosterism and complexing | Q34523552 | ||
Allosteric modulators of G-protein-coupled receptors | Q35559684 | ||
A1 adenosine receptor allosteric enhancer PD-81723 protects against renal ischemia-reperfusion injury | Q36309390 | ||
Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology. | Q36880915 | ||
Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor. | Q37608542 | ||
Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist | Q37674601 | ||
Emerging paradigms in GPCR allostery: implications for drug discovery | Q38125563 | ||
Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization | Q38136285 | ||
Advances in G protein-coupled receptor allostery: from function to structure | Q38233848 | ||
Current status of A1 adenosine receptor allosteric enhancers | Q38542934 | ||
Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation | Q38801257 | ||
A Positive Allosteric Modulator of the Adenosine A1 Receptor Selectively Inhibits Primary Afferent Synaptic Transmission in a Neuropathic Pain Model | Q42701396 | ||
Effects of conformational restriction of 2-amino-3-benzoylthiophenes on A(1) adenosine receptor modulation | Q42921396 | ||
Delineating the mode of action of adenosine A1 receptor allosteric modulators | Q43023574 | ||
Hybrid ortho/allosteric ligands for the adenosine A(1) receptor | Q43117671 | ||
Allosteric adenosine modulation to reduce allodynia | Q43707749 | ||
A structure-activity analysis of biased agonism at the dopamine D2 receptor | Q44234043 | ||
Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-o | Q44483391 | ||
Allosteric modulators of the adenosine A1 receptor: synthesis and pharmacological evaluation of 4-substituted 2-amino-3-benzoylthiophenes. | Q45974813 | ||
Allosteric small molecules unveil a role of an extracellular E2/transmembrane helix 7 junction for G protein-coupled receptor activation | Q46985701 | ||
Quantification of adenosine A(1) receptor biased agonism: Implications for drug discovery. | Q51740302 | ||
Synthesis and characterization of novel 2-amino-3-benzoylthiophene derivatives as biased allosteric agonists and modulators of the adenosine A(1) receptor. | Q51761046 | ||
The synthesis and biological evaluation of 2-amino-4,5,6,7,8,9-hexahydrocycloocta[b]thiophenes as allosteric modulators of the A1 adenosine receptor. | Q51767664 | ||
Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors. | Q51797215 | ||
Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log. | Q52233618 | ||
Allosteric Modulation of G Protein–Coupled Receptors | Q56115675 | ||
Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands | Q57838214 | ||
P433 | issue | 6 | |
P304 | page(s) | 715-725 | |
P577 | publication date | 2016-09-28 | |
P1433 | published in | Molecular Pharmacology | Q1943386 |
P1476 | title | Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity | |
P478 | volume | 90 |
Q47441641 | A monoclonal antibody raised against a thermo-stabilised β1-adrenoceptor interacts with extracellular loop 2 and acts as a negative allosteric modulator of a sub-set of β1-adrenoceptors expressed in stable cell lines. |
Q90646236 | G-Protein-Coupled Receptor-Membrane Interactions Depend on the Receptor Activation State |
Q58080237 | Gaussian accelerated molecular dynamics for elucidation of drug pathways |
Q91710471 | Mechanistic Insights into Specific G Protein Interactions with Adenosine Receptors |
Q52313686 | New Paradigms in Adenosine Receptor Pharmacology: Allostery, Oligomerization and Biased Agonism. |
Q52737158 | Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors. |
Q64055813 | Probe dependence of allosteric enhancers on the binding affinity of adenosine A -receptor agonists at rat and human A -receptors measured using NanoBRET |
Q59340309 | Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A Receptor |
Q59060936 | Structure of the adenosine-bound human adenosine A1 receptor–Gi complex |
Search more.